Teriparatide biosimilar (Gedeon Richter)

特立帕肽生物类似药(Gedeon Richter)

Report date: 2022/03/11 17:24:45

Base Information

Drug NameTeriparatide biosimilar (Gedeon Richter)
Drug Alias Name特立帕肽生物仿制药(Gedeon Richter)特立帕肽生物类似物(Gedeon Richter)TerrosarhPTH (1-34) (Gedeon Richter)
ClassificationBiologics > Protein drugs > Recombinant polypeptideBiologics > Biosimilar
Mechanisms of ActionParathyroid hormone replacements
TargetsParathyroid hormone receptor
Therapy Area/IndicationsFractures, StressOsteoporosis
Global Approved IndicationsOsteoporosis
Approved Indications in ChinaN/A
Original Approved Country/TerritoryEU
Original Approved Date2017/01/04
Country/TerritoryUnited KingdomEUJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesGedeon Richter Plc
China Registration ClassN/A

Develop Information

Inactive CompaniesUniversity Of East Anglia
Active IndicationsOsteoporosis
Inactive IndicationsFractures, Stress

Other Information

ATC CodeH05AA02
Related LinksWikipediaKEGG